Abiopharma

🔍 DAHL JAMES H (Executive)

Company: AMREP CORP. (AXR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 2,060 shares of Common Shares at $27.923 per share (Direct)
  Date: 2026-03-31 | Code: P | equity_swap_involved: 0 | shares_owned_after: 476,458.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: IRA Accounts | shares_owned_after: 229,151.00 | Footnotes: F3
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: Trust | shares_owned_after: 94,120.00 | Footnotes: F4
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 173,750.00 | Footnotes: F5

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.60 to $28.131 per share.
• F2: The shares are held by James H. Dahl.
• F3: The shares are held in two IRA accounts as follows: 204,151 shares held by the ROTH Conversion Account and 25,000 shares held by the IRA Account.
• F4: The shares are held by Dahl Family Foundation, Inc. Neither James H. Dahl nor any member of his family have any pecuniary interest in shares held by Dahl Family Foundation, Inc.
• F5: The shares are held by Rainey E. Lancaster who is a member of a group with James H. Dahl for purposes of Section 13(d) of the Exchange Act.